CPA
VYNT

Court Place Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Court Place Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-67
Closed -$1K – 182
2019
Q3 		$1K Hold
67
– – ﹤0.01% 174
2019
Q2 		$2K Hold
67
– – ﹤0.01% 180
2019
Q1 		$2K Hold
67
– – ﹤0.01% 179
2018
Q4 		$2K Hold
67
– – ﹤0.01% 166
2018
Q3 		$10K Hold
67
– – ﹤0.01% 178
2018
Q2 		$9K Hold
67
– – ﹤0.01% 173
2018
Q1 		$17K Buy
+67
New +$18.9K 0.01% 170

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Court Place Advisors's VYNT Position: Q4 2019 in Review

Court Place Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2019, closing a stake of 67 shares — an estimated $1K sold.

Court Place Advisors first reported a position in VYNT in Q1 2018 and held it in 7 quarters. The position peaked at $17K in Q1 2018. 18 funds tracked by Wall St. Rank hold VYNT as of Q4 2019.

  • Court Place Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Court Place Advisors sold 67 Vyant Bio, Inc. Common Stock shares in Q4 2019, an estimated $1K.
  • Court Place Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
  • Court Place Advisors's Vyant Bio, Inc. Common Stock position peaked at $17K in Q1 2018.
  • 18 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2019.

Based on Court Place Advisors's 13F filing for Q4 2019, filed 28 Jan 2020.